dc.contributor.author | GELİNCİK, Aslı | |
dc.contributor.author | Erdenen, Fusun | |
dc.contributor.author | Ersoy, Ramazan | |
dc.contributor.author | Kutlu, Ali | |
dc.contributor.author | Talay, Fahrettin | |
dc.contributor.author | Colakoglu, Bahattin | |
dc.contributor.author | Buyukozturk, Suna | |
dc.contributor.author | ÖZŞEKER, ZEYNEP FERHAN | |
dc.contributor.author | Bulut, Ismet | |
dc.contributor.author | Erdogdu, Derya | |
dc.date.accessioned | 2022-02-18T11:30:10Z | |
dc.date.available | 2022-02-18T11:30:10Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | ÖZŞEKER Z. F. , Bulut I., Erdogdu D., GELİNCİK A., Erdenen F., Ersoy R., Kutlu A., Talay F., Colakoglu B., Buyukozturk S., "Comparision Between Treatment Persistence With Omalizumab in Severe Allergic Asthma and Subcutaneous Immunotherapy in Severe Allergic Rhinitis", CHEST, cilt.144, sa.4, 2013 | |
dc.identifier.issn | 0012-3692 | |
dc.identifier.other | av_ff8c8e7c-08e1-44af-8d68-c9578592d589 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/181330 | |
dc.identifier.uri | https://doi.org/10.1378/chest.1703095 | |
dc.language.iso | eng | |
dc.subject | Respiratory Care | |
dc.subject | YOĞUN BAKIM | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | SOLUNUM SİSTEMİ | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Göğüs Hastalıkları ve Allerji | |
dc.subject | İç Hastalıkları | |
dc.subject | Yoğun Bakım | |
dc.subject | Critical Care and Intensive Care Medicine | |
dc.subject | Pulmonary and Respiratory Medicine | |
dc.subject | Health Sciences | |
dc.title | Comparision Between Treatment Persistence With Omalizumab in Severe Allergic Asthma and Subcutaneous Immunotherapy in Severe Allergic Rhinitis | |
dc.type | Makale | |
dc.relation.journal | CHEST | |
dc.contributor.department | , , | |
dc.identifier.volume | 144 | |
dc.identifier.issue | 4 | |
dc.contributor.firstauthorID | 3381368 | |